COVID-19: Home Test to Treat Program, Vaccine Safety Concern
Jan. 17, 2023 ||The National Institutes of Health launches the Home Test to Treat program; FDA and CDC report a COVID-19 vaccine safety concern for those ages 65 and older.
view more »The National Institutes of Health launches the Home Test to Treat program; FDA and CDC report a COVID-19 vaccine safety concern for those ages 65 and older.
view more »FDA and CDC say Evusheld is unlikely to neutralize the XBB.1.5 subvariant, and a CDC report indicates COVID-19 vaccination in children and adolescents is highest among Asian and Hispanic youth.
view more »FDA approves the use of Actemra, a monoclonal antibody treatment, as COVID-19 cases caused by the XBB.1.5 subvariant of SARS-CoV-2 spike.
view more »Americans again can request four no-cost, at-home COVID-19 tests per address; FDA's vaccine committee will meet in January to develop a long-term strategy.
view more »Flexible policies in Oregon and Colorado support health care providers amid a steady increase in respiratory syncytial virus (RSV), influenza, and COVID-19.
view more »CDC expands its recommendation for bivalent COVID-19 vaccines for children ages 6 months to 5 years old as health agencies confront low vaccination rates among children.
view more »FDA pauses its emergency use authorization of bebtelovimab, which does not protect against prevalent SARS-CoV-2 subvariants; CDC updates its guidance for managing COVID-19 in congregate living settings to align with previous guidance.
view more »New COVID-19 vaccine initiatives seek to address access inequalities, and NIH launches a website where Americans can self-report COVID-19 test results anonymously to provide data to public health departments.
view more »A coalition of 22 states argues that the vaccine mandate has intensified workforce shortages at health care facilities and limited patient access to care.
view more »Pfizer-BioNTech and Moderna data indicate that bivalent vaccines provide greater protection than the original monovalent vaccine against the emerging BQ.1.1 omicron subvariant, while the CDC reports low COVID-19 vaccination numbers among children.
view more »Maryland, Oregon, and Colorado provided funding and regulatory flexibility to health care providers amid a surge in pediatric respiratory syncytial virus cases.
view more »At a Nov. 14 listening session, HHS leaders announced plans to launch in 2023 a learning community focused on patient and health care worker safety.
view more »The agency shares toolkits to help acute-care, long-term care, and ambulatory care facilities adopt the Four Moments of Antibiotic Decision Making framework.
view more »The agency shared three sample formats to help hospital staff build machine readable files to comply with the Hospital Price Transparency Rule.
view more »A JAMA Network open study highlights disparities in access to Test-to-Treat sites; the Biden administration holds a White House COVID-19 Equity Summit.
view more »The CMS Innovation Center shares a progress report on its 10-year strategy and a blog post announcing plans to improve integrated specialty care.
view more »A new report from the Department of Veterans Affairs indicates that Paxlovid can reduce risk of long COVID-19; new data show Pfizer bivalent COVID-19 booster vaccines substantially increase immune responses compared with monovalent vaccines.
view more »The rule finalizes the conversion factor and includes reimbursement provisions for telehealth and behavioral health services, the Quality Payment Program, and the Medicare Shared Savings Program.
view more »President Joe Biden urges Americans to get their updated COVID-19 vaccine, which protects against the original SARS-CoV-2 variant and BA.4 and BA.5 subvariants.
view more »A CDC committee recommends the inclusion of COVID-19 vaccines in the 2023 immunization schedule; the administration releases a biodefense strategy.
view more »CDC recommends for younger age groups updated Pfizer and Moderna COVID-19 booster vaccines that target the BA.4 and BA.5 subvariants of SARS-CoV-2.
view more »International Infection Prevention Week, Oct. 16–22, highlights infection preventionists' role in protecting public health through education.
view more »CMS extends for two years the Bundled Payments for Care Improvement Advanced Model and alters the accounting process for beneficiaries with COVID-19.
view more »Effective Oct. 13, Health and Human Services Secretary Xavier Becerra renewed the COVID-19 public health emergency determination.
view more »HHS links COVID-19 vaccinations to fewer COVID-19 hospitalizations and deaths, and NIH details its plan to study long COVID-19 effects.
view more »CDC issued a health advisory reminding health care providers to remain aware of a patient’s international travel history.
view more »FDA now urges COVID-19 test developers to take traditional premarket review pathways, and HHS will cover the cost of 60,000 bebtelovimab doses.
view more »CDC reports lower in-hospital mortality rates from the omicron variant, providers have until Sept. 30 to report period 3 Provider Relief Fund spending.
view more »America's Essential Hospitals urges CMS to swiftly restore full Medicare Part B drug payment rates for hospitals in the 340B Drug Pricing Program and define a select group of hospitals with a safety net mission.
view more »The Biden administration's fall plan to manage the COVID-19 pandemic includes securing millions of updated vaccines and additional at-home, rapid tests; ensuring vaccine access for higher-risk Americans; and fostering community conversations about updated vaccines.
view more »The agency requests information on health care access and equity, provider experiences, and the effect of policies introduced in response to COVID-19.
view more »